McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates
McKesson (MCK) came out with quarterly earnings of $8.26 per share, beating the Zacks Consensus Estimate of $8.23 per share. This compares to earnings of $7.88 per share a year ago.
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why McKesson (MCK) Dipped More Than Broader Market Today
McKesson (MCK) reached $693.54 at the closing of the latest trading day, reflecting a -2.99% change compared to its last close.
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging McKesson (MCK) This Year?
Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
McKesson Defied The Doubters (Including Me)--And Could Do It Again
McKesson delivered strong double-digit growth in revenue, earnings, and free cash flow in fiscal 2025, outperforming the S&P 500 significantly. The planned spin-off of the underperforming Medical-Surgical Solutions segment will sharpen McKesson's focus on higher-growth, higher-margin oncology and biopharma businesses. Management and analysts expect continued double-digit earnings growth, supported by robust share buybacks and optimistic long-term guidance.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Here's Why McKesson (MCK) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why McKesson (MCK) Dipped More Than Broader Market Today
McKesson (MCK) concluded the recent trading session at $724.11, signifying a -1.53% move from its prior day's close.
